Altered RNA splicing initiates the viral mimicry response from inverted SINEs following type I PRMT inhibition in triple-negative breast cancer

Altered RNA splicing initiates the viral mimicry response from inverted SINEs following type I PRMT inhibition in triple-negative breast cancer

Bibliographic Details
Main Authors:	Arrowsmith, C, Wu, Q, Nie, D, Alawi, W, Mehdipour, P, Et al.
Format:	Journal article
Language:	English
Published:	Research Square 2021

Similar Items

PRMT inhibition induces a viral mimicry response in triple-negative breast cancer
by: Wu, Q, et al.
Published: (2022)

Retroelement decay by the exonuclease XRN1 is a viral mimicry dependency in cancer
by: Hosseini, A, et al.
Published: (2024)

Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependency
by: Mehdipour, P, et al.
Published: (2020)

Advanced Triple Negative Breast Cancer in Pregnancy
by: Tze Huat Chong, et al.
Published: (2020)

Locoregional treatments for triple-negative breast cancer.
by: Eiermann, W, et al.
Published: (2012)

Triple negative breast cancer: The role of metabolic pathways
by: Dean, S.J.R., et al.
Published: (2014)

Adaptation to chronic hypoxia in triple-negative breast cancer
by: Hartley, F
Published: (2023)

Sustained cancer‐relevant alternative RNA splicing events driven by PRMT5 in high‐risk neuroblastoma
by: Bate‐Eya, LT, et al.
Published: (2024)

Common breast cancer susceptibility loci are associated with triple-negative breast cancer.
by: Stevens, K, et al.
Published: (2011)

Inhibiting EZH2 targets atypical teratoid rhabdoid tumor by triggering viral mimicry via both RNA and DNA sensing pathways
by: Feng, S, et al.
Published: (2024)

Recent advances in nanotheranostics for triple negative breast cancer treatment
by: Thakur, Vikram, et al.
Published: (2019)

MENA Confers Resistance to Paclitaxel in Triple-Negative Breast Cancer
by: Han, Sangyoon, et al.
Published: (2018)

Study metastatic properties of triple negative breast cancer cells.
by: Zhou, Yinning.
Published: (2013)

Targeting EGFR signalling pathway in triple negative breast cancer
by: Albukhari, A
Published: (2014)

Targeting EGFR signalling pathway in triple negative breast cancer
by: Albukhari, A
Published: (2014)

The biological characterisation of triple negative breast cancer in cyclic hypoxia
by: Simpson, C
Published: (2021)

CDK9 inhibition activates innate immune response through viral mimicry
by: Yalala, S, et al.
Published: (2024)

Understanding the role of PRMT5 in neuroblastoma
by: Albayrak, G
Published: (2023)

CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer
by: Wang, Yubao, et al.
Published: (2017)

Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer
by: Shu, Shaokun, et al.
Published: (2017)

Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers
by: Hancock, BA, et al.
Published: (2019)

The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer
by: Abraham, JE, et al.
Published: (2024)

Acquired resistance to HSP90 inhibition in triple-negative breast cancer
by: Mumin, D
Published: (2016)

Targeting PRMT5 impairs cancer proliferation through splicing but promotes state shifts that enable resistance and disease progression
by: Fowler, Colin E.
Published: (2024)

Clinical characteristics of triple-negative breast cancer: experience in an Asian developing country.
by: Tan, G.H., et al.
Published: (2009)

A clinicopathologic study on triple-negative breast cancer patients: HUSM experience
by: Saidin, Usman Sani
Published: (2011)

Genetic determinants of TAC chemotherapy response in triple negative breast cancer patients
by: Aziz, Ahmad Aizat Abdul
Published: (2018)

Mechanisms and consequences of resistance to PRMT5 Inhibition
by: Mueller, Helen S.
Published: (2022)

PRMT5 Inhibitors in Merkel Cell Carcinoma
by: Higgins, Kathleen Whitmore
Published: (2024)

PRMT5 controls the innate immune response
by: Zhang, C
Published: (2024)

Sine-based barnacle mating optimization for PD control of an inverted pendulum system
by: Muhammad Almaa Anwari, Roslan, et al.
Published: (2022)

Spectacular batesian mimicry in ants
by: Hashim, Rosli, et al.
Published: (2004)

Apoptosis and cell cycle mechanisms of ampelopsin E on triple negative breast cancer cells
by: Abd Rahman, Napsiah
Published: (2017)

Regulation of Cellular Heterogeneity and Rates of Symmetric and Asymmetric Divisions in Triple-Negative Breast Cancer
by: Granit, Roy Z., et al.
Published: (2018)

Study of tumor-associated macrophages in triple-negative breast cancer and their correlation with clinicopathological parameters
by: Priyalatha Kurusamy
Published: (2014)

Chemical space mimicry for drug discovery
by: Yuan, W, et al.
Published: (2017)

Targeted delivery of vitamin E TPGS based nanomedicine for treatment of triple negative breast cancer
by: Rajaletchumy, Veloo Kutty
Published: (2015)

Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in Mouse Models of Triple-Negative Breast Cancer
by: Murphy, Charles J., et al.
Published: (2019)

19p13.1 is a triple-negative-specific breast cancer susceptibility locus.
by: Stevens, K, et al.
Published: (2012)

Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancer
by: Alkhatib, Heba, et al.
Published: (2024)